Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke "REMEDY"

Recruiting

Phase 2 Results N/A

Summary of Purpose

This is a Phase II study to assess the safety and tolerability of DM199 in acute ischemic stroke patients. The study will be randomized, placebo controlled at multiple centers.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 April 2018.

19 Jan 2018 18 Sep 2017 30 Apr 2019 20 Jun 2019 1 Apr 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts